First Trust Advisors LP acquired a new position in Envision Healthcare Co. (NYSE:EVHC) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 93,767 shares of the company’s stock, valued at approximately $3,241,000.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in EVHC. OZ Management LP purchased a new position in shares of Envision Healthcare in the third quarter worth about $131,987,000. Douglas Lane & Associates LLC increased its holdings in Envision Healthcare by 512.8% during the 4th quarter. Douglas Lane & Associates LLC now owns 672,252 shares of the company’s stock valued at $23,233,000 after purchasing an additional 562,554 shares during the period. Westfield Capital Management Co. LP increased its holdings in Envision Healthcare by 72.0% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,259,300 shares of the company’s stock valued at $56,606,000 after purchasing an additional 527,015 shares during the period. JPMorgan Chase & Co. increased its holdings in Envision Healthcare by 420.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 592,805 shares of the company’s stock valued at $26,083,000 after purchasing an additional 478,926 shares during the period. Finally, Dimensional Fund Advisors LP increased its holdings in Envision Healthcare by 21.6% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,986,612 shares of the company’s stock valued at $89,289,000 after purchasing an additional 352,654 shares during the period.
Envision Healthcare Co. (NYSE EVHC) opened at $42.72 on Wednesday. Envision Healthcare Co. has a twelve month low of $23.77 and a twelve month high of $66.39. The company has a current ratio of 3.40, a quick ratio of 3.38 and a debt-to-equity ratio of 0.87. The firm has a market capitalization of $5,260.00, a P/E ratio of 19.96, a price-to-earnings-growth ratio of 1.09 and a beta of 0.48.
EVHC has been the topic of a number of research analyst reports. KeyCorp set a $40.00 price target on Envision Healthcare and gave the company a “buy” rating in a report on Tuesday, November 14th. Cantor Fitzgerald restated a “hold” rating and set a $30.00 price target on shares of Envision Healthcare in a report on Tuesday, November 14th. Robert W. Baird set a $35.00 price target on Envision Healthcare and gave the company a “buy” rating in a report on Tuesday, November 14th. Mizuho set a $31.00 price target on Envision Healthcare and gave the company a “neutral” rating in a report on Friday, November 17th. Finally, Credit Suisse Group initiated coverage on Envision Healthcare in a report on Monday, December 11th. They set an “outperform” rating and a $36.00 price target on the stock. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and nine have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $42.57.
TRADEMARK VIOLATION NOTICE: This piece of content was posted by Ticker Report and is the property of of Ticker Report. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of international copyright legislation. The correct version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3261045/93767-shares-in-envision-healthcare-co-evhc-acquired-by-first-trust-advisors-lp.html.
Envision Healthcare Company Profile
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Want to see what other hedge funds are holding EVHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envision Healthcare Co. (NYSE:EVHC).
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.